ExodusPoint Capital Management, LP - ATEA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$87
-44.9%
28,854
-31.7%
0.00%0.0%
Q2 2023$158
-99.8%
42,235
+274.0%
0.00%0.0%
Q3 2022$64,000
-22.9%
11,293
-3.7%
0.00%0.0%
Q2 2022$83,000
-61.2%
11,727
-51.1%
0.00%
-50.0%
Q4 2021$214,00023,9590.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,637,331$57,405,00037.04%
Bain Capital Life Sciences Investors, LLC 3,700,000$129,722,0008.05%
Cormorant Asset Management, LP 4,928,756$172,802,0007.02%
RA Capital Management 5,427,655$190,294,0002.64%
CM Management, LLC 100,000$3,506,0002.62%
Ghost Tree Capital, LLC 150,000$5,259,0001.54%
ORACLE INVESTMENT MANAGEMENT INC 309,126$10,838,0001.35%
Perceptive Advisors 2,259,224$79,208,0001.15%
Omega Fund Management, LLC 164,577$5,770,0000.65%
Monashee Investment Management LLC 100,000$3,506,0000.65%
View complete list of ATEA PHARMACEUTICALS INC shareholders